Literature DB >> 16618388

The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer.

Debra L Bemis1, Jillian L Capodice, Jennifer E Costello, George C Vorys, Aaron E Katz, Ralph Buttyan.   

Abstract

Having a high probability of experiencing prostate cancer during their lifetime, men are increasingly seeking protection against this disease with the use of over-the-counter dietary supplements containing herbs, vitamins, or plant-derived biochemical agents. The use of these agents for prostate cancer prevention is driven by epidemiology supporting the idea that regional diets and consumption of specific dietary components (certain herbs, vitamins, isoflavones, and polyphenols) are associated with a lower risk for prostate cancer, in conjunction with basic research that is defining molecules within food substances that kill or suppress growth of cultured human prostate cancer cells. Moreover, there is a sense that these dietary agents lack side effects, although this assumption often is faulty. Unfortunately, at this time, there is insufficient clinical evidence to support the widespread use of these dietary supplements for chemoprevention of prostate cancer, although ongoing clinical trials of the most promising vitamins and minerals are approaching conclusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618388     DOI: 10.1007/s11912-006-0024-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  90 in total

1.  Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis.

Authors:  K Imaida; S Tamano; K Kato; Y Ikeda; M Asamoto; S Takahashi; Z Nir; M Murakoshi; H Nishino; T Shirai
Journal:  Carcinogenesis       Date:  2001-03       Impact factor: 4.944

2.  A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.

Authors:  Aminah Jatoi; Neil Ellison; Patrick A Burch; Jeff A Sloan; Shaker R Dakhil; Paul Novotny; Winston Tan; Tom R Fitch; Kendrith M Rowland; Charles Y F Young; Patrick J Flynn
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

3.  A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach.

Authors:  E Choan; Roanne Segal; Derek Jonker; Shawn Malone; Neil Reaume; Libni Eapen; Victor Gallant
Journal:  Urol Oncol       Date:  2005 Mar-Apr       Impact factor: 3.498

Review 4.  Prostate cancer chemoprevention by green tea.

Authors:  S Gupta; N Ahmad; H Mukhtar
Journal:  Semin Urol Oncol       Date:  1999-05

5.  Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice.

Authors:  Lili Tang; Taiyi Jin; Xiangbin Zeng; Jia-Sheng Wang
Journal:  J Nutr       Date:  2005-02       Impact factor: 4.798

6.  Genistein, a specific inhibitor of tyrosine-specific protein kinases.

Authors:  T Akiyama; J Ishida; S Nakagawa; H Ogawara; S Watanabe; N Itoh; M Shibuya; Y Fukami
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

7.  Intake of carotenoids and retinol in relation to risk of prostate cancer.

Authors:  E Giovannucci; A Ascherio; E B Rimm; M J Stampfer; G A Colditz; W C Willett
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

8.  Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.

Authors:  Kedar Hastak; Sanjay Gupta; Nihal Ahmad; Mukesh K Agarwal; Munna L Agarwal; Hasan Mukhtar
Journal:  Oncogene       Date:  2003-07-31       Impact factor: 9.867

9.  Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines.

Authors:  Vasundara Venkateswaran; Neil E Fleshner; Laurence H Klotz
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

Review 10.  Epidemiology of prostate cancer.

Authors:  E David Crawford
Journal:  Urology       Date:  2003-12-22       Impact factor: 2.649

View more
  2 in total

Review 1.  Dietary interventions in prostate cancer.

Authors:  Wendy Demark-Wahnefried
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

2.  Aqueous Extract of Shi-Liu-Wei-Liu-Qi-Yin Induces G2/M Phase Arrest and Apoptosis in Human Bladder Carcinoma Cells via Fas and Mitochondrial Pathway.

Authors:  Ting-Tsz Ou; Chau-Jong Wang; Guang-Uei Hung; Cheng-Hsun Wu; Huei-Jane Lee
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-03       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.